Investigating the Oncogenic and Immunological Implications of YTHDF1 in Ovarian Cancer
These findings position YTHDF1 as a promising prognostic biomarker and therapeutic target for OC. Its role in shaping an immunosuppressive microenvironment and mediating chemoresistance underscores its potential in enhancing immunotherapy and improving chemotherapy outcomes.
Authors
- Huijuan Zhou (ORCID: https://orcid.org/0000-0001-5358-8010)
- Bo Yin (ORCID: https://orcid.org/0000-0001-9966-5835)
Institutions
- Shanghai First Maternity and Infant Hospital (CN)
Publication Details
- Journal
- Biologics
- Published
- 2025-08-01
- DOI
- https://doi.org/10.2147/btt.s542488
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81